Technology | Vascular Access | September 03, 2019

Adept Medical Launches Antegrade IR Platform

Platform provides work surface for antegrade femoral approach during vascular interventional procedures

Adept Medical Launches Antegrade IR Platform

September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven, it is placed to provide an ideal work surface for antegrade femoral approach during interventional radiology vascular procedures. The device sits within the company’s existing range of access and patient positioning devices designed for interventional radiology, cardiology and vascular procedures.

Designed to provide a stable, radiolucent, height- and length-appropriate work surface for supporting lightweight equipment during the antegrade femoral approach, the Antegrade IR Platform offers clinical benefits to the current practice of laying procedural equipment on the mattress and patient. 

The narrow portion of the Antegrade IR Platform extends alongside the patient towards the femoral artery, offering a steady platform for the clinician to rest their wrists on during wire manipulation. It can be set up at two different lengths and various heights according to the patient and procedure, providing flexibility. 

Ideally used in conjunction with the Adept Medical Drape Support (AM1000) and ArmSure (AM0600), these two products offer drape management, patient comfort and security during interventional radiology procedures. 

Crafted from carbon fiber composite and high-performance engineering plastics, the Antegrade IR Platform is lightweight yet strong, and has a high resistance to chemical attack from commonly used cleaning products. 

For more information:

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init